Symbols / CLBT Stock $13.81 -3.36% Cellebrite DI Ltd.
CLBT (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
Official websiteCellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, and intellectual property theft, as well as financial crimes, including those involving cryptocurrency. It also offers Inseyets, digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations; Guardian Forensics, an evidence management solution which enables customers to manage their digital forensics workflows, and to store, share and review digital evidence; Guardian Collaborate, a digital evidence sharing tool; and Guardian Investigate, a case management and AI-powered analytics solution. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence and enables actionable insights into a range of crime types; Corellium Falcon for conducting mobile vulnerability research, exploit introspection, and malware analysis; and Corellium Viper for mobile application penetration testing capabilities. Further, the company offers professional services, such as training and certification services, and advanced services. It serves federal, state, and local agencies, as well as corporations and service providers. The company is headquartered in Petah Tikva, Israel.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-05-27 | init | DA Davidson | — → Buy | $20 |
| 2026-05-15 | main | Needham | Buy → Buy | $15 |
| 2026-02-12 | main | Needham | Buy → Buy | $18 |
| 2025-11-13 | main | JP Morgan | Overweight → Overweight | $24 |
| 2025-11-13 | main | Lake Street | Buy → Buy | $23 |
| 2025-11-13 | main | B of A Securities | Buy → Buy | $25 |
| 2025-11-13 | main | Needham | Buy → Buy | $24 |
| 2025-09-24 | main | JP Morgan | Overweight → Overweight | $23 |
| 2025-08-15 | main | Lake Street | Buy → Buy | $22 |
| 2025-08-14 | main | Needham | Buy → Buy | $18 |
| 2025-06-23 | main | JP Morgan | Overweight → Overweight | $20 |
| 2025-06-06 | reit | Needham | Buy → Buy | $24 |
| 2025-05-15 | main | JP Morgan | Overweight → Overweight | $22 |
| 2025-05-14 | main | Needham | Buy → Buy | $24 |
| 2025-05-12 | main | JP Morgan | Overweight → Overweight | $25 |
| 2025-04-02 | reit | Needham | Buy → Buy | $28 |
| 2025-03-27 | reit | Needham | Buy → Buy | $28 |
| 2025-03-10 | reit | Needham | Buy → Buy | $28 |
| 2025-02-14 | main | Lake Street | Buy → Buy | $26 |
| 2025-02-14 | reit | Needham | Buy → Buy | $28 |
- Deep dive into Cellebrite's Genesis AI investigations platform on June 10 - Stock Titan Fri, 05 Jun 2026 12
- Tracking How the Cellebrite (CLBT) Investment Narrative Is Evolving Without New Analyst Targets - Yahoo Finance hu, 04 Jun 2026 19
- Cellebrite Q1 2026 Beat Fuels 99% Upside Case for CLBT Stock - TIKR.com Fri, 15 May 2026 07
- CLBT News | CELLEBRITE DI LTD (NASDAQ:CLBT) - ChartMill Wed, 03 Jun 2026 07
- $CLBT stock is up 10% today. Here's what we see in our data. - Quiver Quantitative Fri, 29 May 2026 19
- (CLBT) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily Wed, 03 Jun 2026 09
- TD Cowen reiterates Buy rating on Cellebrite stock at $23 target - Investing.com Nigeria hu, 04 Jun 2026 21
- Cellebrite DI (CLBT) Is Up 20.4% After FedRAMP Win And AI Launch Momentum - Has The Bull Case Changed? - simplywall.st Mon, 01 Jun 2026 23
- Analysts Offer Insights on Technology Companies: Broadcom (AVGO), Gorilla Technology Group Inc. (GRRR) and Cellebrite DI (CLBT) - The Globe and Mail Fri, 05 Jun 2026 14
- 126,264-share resale planned for CLBT (NASDAQ: CLBT) via Morgan Stanley - Stock Titan Mon, 01 Jun 2026 20
- CLBT Stock Chart | CELLEBRITE DI LTD (NASDAQ:CLBT) - ChartMill Fri, 29 May 2026 07
- Is It Time To Reassess Cellebrite DI (CLBT) After The Recent Share Price Rebound? - simplywall.st Sun, 31 May 2026 09
- Is Cellebrite DI Ltd. (CLBT) A Good Stock To Buy Now? - Yahoo Finance Sun, 26 Apr 2026 07
- Cellebrite (CLBT) CRO Jewell sells 12,658 shares tied to RSU tax obligations - Stock Titan ue, 19 May 2026 07
- CGNT vs. CLBT: Which Intelligence Software Stock Offers Better Upside? - Yahoo Finance Mon, 25 May 2026 07
Insider Transactions
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
475.68
+18.56%
|
401.20
+23.41%
|
325.11
+20.12%
|
270.65
|
| Operating Revenue |
|
475.68
+18.56%
|
401.20
+23.41%
|
325.11
+20.12%
|
270.65
|
| Cost Of Revenue |
|
75.17
+20.10%
|
62.59
+17.59%
|
53.23
+4.90%
|
50.75
|
| Reconciled Cost Of Revenue |
|
75.17
+20.10%
|
62.59
+17.59%
|
53.23
+4.90%
|
50.75
|
| Gross Profit |
|
400.50
+18.28%
|
338.61
+24.54%
|
271.88
+23.63%
|
219.91
|
| Operating Expense |
|
334.02
+18.57%
|
281.70
+18.04%
|
238.64
+9.04%
|
218.86
|
| Research And Development |
|
113.88
+15.71%
|
98.42
+16.62%
|
84.39
+4.67%
|
80.62
|
| Selling General And Administration |
|
220.15
+20.11%
|
183.29
+18.82%
|
154.26
+11.58%
|
138.24
|
| Selling And Marketing Expense |
|
154.81
+16.94%
|
132.39
+19.47%
|
110.81
+13.79%
|
97.39
|
| General And Administrative Expense |
|
65.33
+28.35%
|
50.90
+17.17%
|
43.44
+6.34%
|
40.85
|
| Salaries And Wages |
|
—
|
—
|
—
|
—
|
| Other Gand A |
|
65.33
+28.35%
|
50.90
+17.17%
|
43.44
+6.34%
|
40.85
|
| Total Expenses |
|
409.19
+18.85%
|
344.30
+17.96%
|
291.87
+8.26%
|
269.61
|
| Operating Income |
|
66.48
+16.82%
|
56.91
+71.21%
|
33.24
+3083.62%
|
1.04
|
| Total Operating Income As Reported |
|
66.48
+16.82%
|
56.91
+71.21%
|
33.24
+3083.62%
|
1.04
|
| EBITDA |
|
103.07
+138.84%
|
-265.35
-305.66%
|
-65.41
-150.28%
|
130.10
|
| Normalized EBITDA |
|
102.33
+138.76%
|
-264.00
-302.33%
|
-65.62
-150.76%
|
129.26
|
| Reconciled Depreciation |
|
11.87
+11.88%
|
10.61
+5.95%
|
10.01
+8.89%
|
9.19
|
| EBIT |
|
91.20
+133.05%
|
-275.95
-265.88%
|
-75.42
-162.38%
|
120.91
|
| Total Unusual Items |
|
0.74
+154.63%
|
-1.35
-754.85%
|
0.21
-75.62%
|
0.84
|
| Total Unusual Items Excluding Goodwill |
|
0.74
+154.63%
|
-1.35
-754.85%
|
0.21
-75.62%
|
0.84
|
| Net Income |
|
78.33
+127.68%
|
-283.01
-248.96%
|
-81.10
-167.13%
|
120.81
|
| Pretax Income |
|
90.68
+132.86%
|
-275.98
-265.24%
|
-75.56
-162.57%
|
120.76
|
| Net Non Operating Interest Income Expense |
|
23.46
+107.08%
|
-331.54
-204.15%
|
-109.01
-191.70%
|
118.87
|
| Interest Expense Non Operating |
|
0.52
+1703.45%
|
0.03
-79.43%
|
0.14
-5.37%
|
0.15
|
| Net Interest Income |
|
23.46
+107.08%
|
-331.54
-204.15%
|
-109.01
-191.70%
|
118.87
|
| Interest Expense |
|
0.52
+1703.45%
|
0.03
-79.43%
|
0.14
-5.37%
|
0.15
|
| Interest Income Non Operating |
|
23.94
+31.35%
|
18.23
+72.38%
|
10.57
+422.22%
|
2.02
|
| Interest Income |
|
23.94
+31.35%
|
18.23
+72.38%
|
10.57
+422.22%
|
2.02
|
| Other Income Expense |
|
0.74
+154.63%
|
-1.35
-754.85%
|
0.21
-75.62%
|
0.84
|
| Gain On Sale Of Security |
|
0.74
+154.63%
|
-1.35
-754.85%
|
0.21
-75.62%
|
0.84
|
| Tax Provision |
|
12.35
+75.88%
|
7.02
+26.84%
|
5.54
+12404.44%
|
-0.04
|
| Tax Rate For Calcs |
|
0.00
-40.87%
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.10
+132.30%
|
-0.31
-754.85%
|
0.05
-75.62%
|
0.19
|
| Net Income Including Noncontrolling Interests |
|
78.33
+127.68%
|
-283.01
-248.96%
|
-81.10
-167.13%
|
120.81
|
| Net Income From Continuing Operation Net Minority Interest |
|
78.33
+127.68%
|
-283.01
-248.96%
|
-81.10
-167.13%
|
120.81
|
| Net Income From Continuing And Discontinued Operation |
|
78.33
+127.68%
|
-283.01
-248.96%
|
-81.10
-167.13%
|
120.81
|
| Net Income Continuous Operations |
|
78.33
+127.68%
|
-283.01
-248.96%
|
-81.10
-167.13%
|
120.81
|
| Normalized Income |
|
77.69
+127.55%
|
-281.97
-247.00%
|
-81.26
-167.63%
|
120.15
|
| Net Income Common Stockholders |
|
77.81
+127.50%
|
-283.01
-248.96%
|
-81.10
-169.85%
|
116.11
|
| Otherunder Preferred Stock Dividend |
|
0.51
|
0.00
|
0.00
-100.00%
|
4.69
|
| Diluted EPS |
|
0.31
+122.96%
|
-1.35
-213.95%
|
-0.43
-172.88%
|
0.59
|
| Basic EPS |
|
0.32
+123.70%
|
-1.35
-213.95%
|
-0.43
-167.19%
|
0.64
|
| Basic Average Shares |
|
241.63
+15.35%
|
209.47
+10.16%
|
190.15
+4.08%
|
182.69
|
| Diluted Average Shares |
|
249.90
+19.30%
|
209.47
+10.16%
|
190.15
-2.68%
|
195.39
|
| Diluted NI Availto Com Stockholders |
|
77.81
+127.50%
|
-283.01
-248.96%
|
-81.10
-169.85%
|
116.11
|
| Depreciation Amortization Depletion Income Statement |
|
—
|
—
|
—
|
—
|
| Depreciation And Amortization In Income Statement |
|
—
|
—
|
—
|
—
|
| Depreciation Income Statement |
|
—
|
—
|
—
|
—
|
| Provision For Doubtful Accounts |
|
—
|
—
|
—
|
—
|
| Rent And Landing Fees |
|
—
|
—
|
—
|
—
|
| Rent Expense Supplemental |
|
—
|
—
|
—
|
—
|
| Total Other Finance Cost |
|
-0.04
-100.01%
|
349.74
+192.82%
|
119.44
+202.09%
|
-117.00
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
938.85
+35.95%
|
690.57
+29.59%
|
532.88
+32.13%
|
403.29
|
| Current Assets |
|
575.85
+1.45%
|
567.59
+34.47%
|
422.08
+42.63%
|
295.93
|
| Cash Cash Equivalents And Short Term Investments |
|
437.05
-2.27%
|
447.22
+47.64%
|
302.92
+64.97%
|
183.62
|
| Cash And Cash Equivalents |
|
124.46
-35.06%
|
191.66
+1.13%
|
189.52
+116.23%
|
87.64
|
| Other Short Term Investments |
|
312.59
+22.31%
|
255.56
+125.35%
|
113.41
+18.16%
|
95.98
|
| Receivables |
|
104.97
+27.46%
|
82.36
+6.59%
|
77.27
-1.89%
|
78.76
|
| Accounts Receivable |
|
104.97
+27.46%
|
82.36
+6.59%
|
77.27
-1.89%
|
78.76
|
| Gross Accounts Receivable |
|
105.48
+27.16%
|
82.95
+5.20%
|
78.85
-2.25%
|
80.67
|
| Allowance For Doubtful Accounts Receivable |
|
-0.51
+14.81%
|
-0.59
+62.48%
|
-1.58
+16.86%
|
-1.90
|
| Inventory |
|
7.60
-14.95%
|
8.94
-10.07%
|
9.94
-2.32%
|
10.18
|
| Raw Materials |
|
3.87
-34.83%
|
5.93
-24.07%
|
7.82
+4.89%
|
7.45
|
| Finished Goods |
|
3.74
+24.33%
|
3.00
+41.41%
|
2.12
-22.02%
|
2.73
|
| Prepaid Assets |
|
13.15
+20.69%
|
10.89
+14.77%
|
9.49
+10.41%
|
8.60
|
| Current Deferred Assets |
|
6.59
+13.18%
|
5.83
+4.99%
|
5.55
-11.71%
|
6.29
|
| Restricted Cash |
|
—
|
—
|
—
|
—
|
| Hedging Assets Current |
|
2.02
+266.18%
|
0.55
|
—
|
—
|
| Other Current Assets |
|
4.46
-62.23%
|
11.80
-30.22%
|
16.91
+99.20%
|
8.49
|
| Total Non Current Assets |
|
363.00
+195.19%
|
122.97
+10.98%
|
110.80
+3.21%
|
107.36
|
| Net PPE |
|
38.52
+39.56%
|
27.60
-8.48%
|
30.16
-8.37%
|
32.91
|
| Gross PPE |
|
83.27
+23.12%
|
67.64
+6.66%
|
63.41
+5.30%
|
60.22
|
| Accumulated Depreciation |
|
-44.75
-11.78%
|
-40.04
-20.40%
|
-33.25
-21.79%
|
-27.30
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Machinery Furniture Equipment |
|
55.29
+14.22%
|
48.40
+17.76%
|
41.10
+10.07%
|
37.34
|
| Other Properties |
|
16.95
+51.48%
|
11.19
-24.61%
|
14.84
-8.38%
|
16.20
|
| Leases |
|
11.03
+37.19%
|
8.04
+7.74%
|
7.46
+11.85%
|
6.67
|
| Goodwill And Other Intangible Assets |
|
201.03
+402.32%
|
40.02
+6.94%
|
37.42
-1.73%
|
38.08
|
| Goodwill |
|
119.56
+316.38%
|
28.71
+7.03%
|
26.83
+0.00%
|
26.83
|
| Other Intangible Assets |
|
81.47
+620.58%
|
11.31
+6.72%
|
10.59
-5.86%
|
11.25
|
| Investments And Advances |
|
97.96
+167.64%
|
36.60
+26.83%
|
28.86
+30.44%
|
22.12
|
| Non Current Deferred Assets |
|
10.88
-1.73%
|
11.07
+57.63%
|
7.02
-43.86%
|
12.51
|
| Non Current Deferred Taxes Assets |
|
10.88
-1.73%
|
11.07
+57.63%
|
7.02
-43.86%
|
12.51
|
| Other Non Current Assets |
|
14.62
+90.29%
|
7.68
+4.65%
|
7.34
+324.09%
|
1.73
|
| Total Liabilities Net Minority Interest |
|
454.53
+28.20%
|
354.55
-28.90%
|
498.67
+51.38%
|
329.43
|
| Current Liabilities |
|
369.66
+25.09%
|
295.50
+16.42%
|
253.82
+22.16%
|
207.78
|
| Payables And Accrued Expenses |
|
87.42
+18.55%
|
73.74
+41.09%
|
52.27
+5.72%
|
49.44
|
| Payables |
|
29.58
+72.43%
|
17.16
+43.05%
|
11.99
+23.66%
|
9.70
|
| Accounts Payable |
|
16.83
+51.97%
|
11.08
+33.75%
|
8.28
+79.58%
|
4.61
|
| Other Payable |
|
6.59
+23.76%
|
5.32
+84.95%
|
2.88
+28.88%
|
2.23
|
| Current Accrued Expenses |
|
57.84
+2.21%
|
56.59
+40.51%
|
40.27
+1.34%
|
39.74
|
| Employee Benefits |
|
—
|
—
|
—
|
—
|
| Total Tax Payable |
|
6.16
+714.81%
|
0.76
-9.24%
|
0.83
-70.80%
|
2.85
|
| Income Tax Payable |
|
6.16
+714.81%
|
0.76
-9.24%
|
0.83
-70.80%
|
2.85
|
| Current Debt And Capital Lease Obligation |
|
4.00
-3.13%
|
4.12
-17.04%
|
4.97
-0.62%
|
5.00
|
| Current Capital Lease Obligation |
|
4.00
-3.13%
|
4.12
-17.04%
|
4.97
-0.62%
|
5.00
|
| Current Deferred Liabilities |
|
278.24
+27.85%
|
217.64
+10.71%
|
196.59
+28.21%
|
153.34
|
| Current Deferred Revenue |
|
278.24
+27.85%
|
217.64
+10.71%
|
196.59
+28.21%
|
153.34
|
| Total Non Current Liabilities Net Minority Interest |
|
84.88
+43.75%
|
59.05
-75.89%
|
244.85
+101.27%
|
121.65
|
| Long Term Debt And Capital Lease Obligation |
|
18.67
+172.85%
|
6.84
-25.26%
|
9.16
-11.55%
|
10.35
|
| Long Term Capital Lease Obligation |
|
18.67
+172.85%
|
6.84
-25.26%
|
9.16
-11.55%
|
10.35
|
| Non Current Pension And Other Postretirement Benefit Plans |
|
—
|
—
|
—
|
—
|
| Non Current Deferred Liabilities |
|
49.53
+9.46%
|
45.25
-3.93%
|
47.10
+11.68%
|
42.17
|
| Non Current Deferred Revenue |
|
49.53
+9.46%
|
45.25
-3.93%
|
47.10
+11.68%
|
42.17
|
| Other Non Current Liabilities |
|
16.68
+139.82%
|
6.95
-94.83%
|
134.48
+173.83%
|
49.11
|
| Preferred Securities Outside Stock Equity |
|
—
|
—
|
—
|
—
|
| Stockholders Equity |
|
484.32
+44.13%
|
336.02
+882.17%
|
34.21
-53.68%
|
73.86
|
| Common Stock Equity |
|
484.32
+44.13%
|
336.02
+882.17%
|
34.21
-53.68%
|
73.86
|
| Capital Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Common Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Share Issued |
|
248.62
+5.99%
|
234.57
+15.39%
|
203.27
+5.29%
|
193.06
|
| Ordinary Shares Number |
|
248.58
+5.99%
|
234.52
+15.40%
|
203.23
+5.29%
|
193.01
|
| Treasury Shares Number |
|
0.04
+0.00%
|
0.04
+0.00%
|
0.04
+0.00%
|
0.04
|
| Additional Paid In Capital |
|
568.72
+14.00%
|
498.88
+687.64%
|
-84.90
+32.42%
|
-125.62
|
| Retained Earnings |
|
-86.54
+47.51%
|
-164.86
-239.55%
|
118.14
-40.70%
|
199.24
|
| Gains Losses Not Affecting Retained Earnings |
|
2.22
+6.42%
|
2.09
+98.67%
|
1.05
+217.22%
|
0.33
|
| Treasury Stock |
|
0.09
+0.00%
|
0.09
+0.00%
|
0.09
+0.00%
|
0.09
|
| Other Equity Adjustments |
|
2.22
+6.42%
|
2.09
+98.67%
|
1.05
+217.22%
|
0.33
|
| Total Equity Gross Minority Interest |
|
484.32
+44.13%
|
336.02
+882.17%
|
34.21
-53.68%
|
73.86
|
| Total Capitalization |
|
484.32
+44.13%
|
336.02
+882.17%
|
34.21
-53.68%
|
73.86
|
| Working Capital |
|
206.19
-24.22%
|
272.09
+61.71%
|
168.26
+90.87%
|
88.15
|
| Invested Capital |
|
484.32
+44.13%
|
336.02
+882.17%
|
34.21
-53.68%
|
73.86
|
| Total Debt |
|
22.67
+106.67%
|
10.97
-22.37%
|
14.13
-7.99%
|
15.36
|
| Capital Lease Obligations |
|
22.67
+106.67%
|
10.97
-22.37%
|
14.13
-7.99%
|
15.36
|
| Net Tangible Assets |
|
283.29
-4.29%
|
296.00
+9318.31%
|
-3.21
-108.97%
|
35.78
|
| Tangible Book Value |
|
283.29
-4.29%
|
296.00
+9318.31%
|
-3.21
-108.97%
|
35.78
|
| Available For Sale Securities |
|
97.96
+167.64%
|
36.60
+26.83%
|
28.86
+30.44%
|
22.12
|
| Derivative Product Liabilities |
|
—
|
0.00
-100.00%
|
54.12
+170.38%
|
20.02
|
| Investmentin Financial Assets |
|
97.96
+167.64%
|
36.60
+26.83%
|
28.86
+30.44%
|
22.12
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
173.54
+31.30%
|
132.17
+29.51%
|
102.06
+395.98%
|
20.58
|
| Cash Flow From Continuing Operating Activities |
|
173.54
+31.30%
|
132.17
+29.51%
|
102.06
+395.98%
|
20.58
|
| Net Income From Continuing Operations |
|
78.33
+127.68%
|
-283.01
-248.96%
|
-81.10
-167.13%
|
120.81
|
| Depreciation Amortization Depletion |
|
11.87
+11.88%
|
10.61
+5.95%
|
10.01
+8.89%
|
9.19
|
| Depreciation |
|
6.97
-4.00%
|
7.26
+8.91%
|
6.66
+4.65%
|
6.37
|
| Amortization Cash Flow |
|
4.90
+46.28%
|
3.35
+0.06%
|
3.35
+18.44%
|
2.83
|
| Depreciation And Amortization |
|
11.87
+11.88%
|
10.61
+5.95%
|
10.01
+8.89%
|
9.19
|
| Amortization Of Intangibles |
|
4.90
+46.28%
|
3.35
+0.06%
|
3.35
+18.44%
|
2.83
|
| Other Non Cash Items |
|
-8.16
-103.58%
|
228.20
+194.42%
|
77.51
+195.59%
|
-81.08
|
| Stock Based Compensation |
|
44.89
+46.83%
|
30.57
+60.94%
|
19.00
+38.59%
|
13.71
|
| Deferred Tax |
|
0.07
+101.87%
|
-4.01
-178.34%
|
5.12
+314.26%
|
-2.39
|
| Deferred Income Tax |
|
0.07
+101.87%
|
-4.01
-178.34%
|
5.12
+314.26%
|
-2.39
|
| Operating Gains Losses |
|
2.31
-97.91%
|
110.66
+224.51%
|
34.10
+193.52%
|
-36.46
|
| Gain Loss On Investment Securities |
|
—
|
110.66
+224.51%
|
34.10
+193.52%
|
-36.46
|
| Gain Loss On Sale Of PPE |
|
2.31
|
0.00
|
0.00
|
—
|
| Change In Working Capital |
|
46.60
+10.84%
|
42.05
+9.16%
|
38.52
+1466.41%
|
-2.82
|
| Change In Receivables |
|
-15.78
-170.73%
|
-5.83
-356.67%
|
2.27
+117.63%
|
-12.88
|
| Changes In Account Receivables |
|
-15.78
-170.73%
|
-5.83
-356.67%
|
2.27
+117.63%
|
-12.88
|
| Change In Inventory |
|
1.63
+66.19%
|
0.98
+304.12%
|
0.24
+106.60%
|
-3.68
|
| Change In Prepaid Assets |
|
5.61
+75.38%
|
3.20
+134.75%
|
-9.21
-61.82%
|
-5.69
|
| Change In Payables And Accrued Expense |
|
9.19
-54.82%
|
20.34
+359.68%
|
4.42
+130.89%
|
-14.32
|
| Change In Payable |
|
9.19
-54.82%
|
20.34
+359.68%
|
4.42
+130.89%
|
-14.32
|
| Change In Account Payable |
|
4.94
+79.42%
|
2.75
-25.36%
|
3.69
+167.46%
|
-5.47
|
| Change In Other Working Capital |
|
49.77
+123.00%
|
22.32
-51.60%
|
46.11
+18.34%
|
38.97
|
| Change In Other Current Assets |
|
-2.35
-147.08%
|
4.99
+500.16%
|
-1.25
-125.50%
|
4.89
|
| Change In Other Current Liabilities |
|
-1.47
+62.92%
|
-3.96
+2.85%
|
-4.08
+59.65%
|
-10.10
|
| Investing Cash Flow |
|
-268.25
-79.46%
|
-149.47
-563.15%
|
-22.54
+75.29%
|
-91.23
|
| Cash Flow From Continuing Investing Activities |
|
-268.25
-79.46%
|
-149.47
-563.15%
|
-22.54
+75.29%
|
-91.23
|
| Net PPE Purchase And Sale |
|
-13.22
-54.39%
|
-8.57
-63.75%
|
-5.23
+24.16%
|
-6.90
|
| Purchase Of PPE |
|
-13.22
-54.39%
|
-8.57
-63.75%
|
-5.23
+24.16%
|
-6.90
|
| Capital Expenditure |
|
-13.22
-24.66%
|
-10.61
-33.99%
|
-7.92
+12.85%
|
-9.09
|
| Net Investment Purchase And Sale |
|
-107.57
+20.97%
|
-136.12
-830.90%
|
-14.62
+82.20%
|
-82.15
|
| Purchase Of Investment |
|
-508.23
-51.81%
|
-334.79
-131.98%
|
-144.32
+12.73%
|
-165.36
|
| Sale Of Investment |
|
400.66
+101.67%
|
198.67
+53.18%
|
129.69
+55.85%
|
83.22
|
| Net Business Purchase And Sale |
|
-147.46
-5265.94%
|
-2.75
|
0.00
|
0.00
|
| Purchase Of Business |
|
-147.46
-5265.94%
|
-2.75
|
0.00
|
0.00
|
| Net Intangibles Purchase And Sale |
|
0.00
+100.00%
|
-2.04
+23.97%
|
-2.69
-22.81%
|
-2.19
|
| Purchase Of Intangibles |
|
0.00
+100.00%
|
-2.04
+23.97%
|
-2.69
-22.81%
|
-2.19
|
| Financing Cash Flow |
|
25.05
+21.32%
|
20.65
-5.12%
|
21.77
+55.80%
|
13.97
|
| Cash Flow From Continuing Financing Activities |
|
25.05
+21.32%
|
20.65
-5.12%
|
21.77
+55.80%
|
13.97
|
| Net Common Stock Issuance |
|
—
|
—
|
—
|
0.00
|
| Common Stock Payments |
|
—
|
—
|
—
|
0.00
|
| Cash Dividends Paid |
|
—
|
—
|
0.00
|
0.00
|
| Repurchase Of Capital Stock |
|
—
|
—
|
—
|
0.00
|
| Proceeds From Stock Option Exercised |
|
25.05
+21.25%
|
20.66
-5.07%
|
21.77
+55.80%
|
13.97
|
| Net Other Financing Charges |
|
—
|
-0.01
|
—
|
—
|
| Changes In Cash |
|
-69.65
-2179.81%
|
3.35
-96.69%
|
101.28
+278.68%
|
-56.68
|
| Effect Of Exchange Rate Changes |
|
2.45
+303.07%
|
-1.21
-304.92%
|
0.59
+135.83%
|
-1.64
|
| Beginning Cash Position |
|
191.66
+1.13%
|
189.52
+116.23%
|
87.64
-39.96%
|
145.97
|
| End Cash Position |
|
124.46
-35.06%
|
191.66
+1.13%
|
189.52
+116.23%
|
87.64
|
| Free Cash Flow |
|
160.32
+31.88%
|
121.56
+29.13%
|
94.14
+719.18%
|
11.49
|
| Income Tax Paid Supplemental Data |
|
—
|
7.71
-23.30%
|
10.05
+10.98%
|
9.05
|
| Amortization Of Securities |
|
-2.37
+18.35%
|
-2.90
-162.57%
|
-1.11
-197.31%
|
-0.37
|
| Issuance Of Capital Stock |
|
—
|
—
|
—
|
—
|
| Net Preferred Stock Issuance |
|
—
|
—
|
—
|
—
|
| Preferred Stock Issuance |
|
—
|
—
|
—
|
—
|
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|